pharmaphorum
JUNE 7, 2021
Researchers in the US have developed a wearable fabric that can sense, store and analyse data that could be used to measure physiological functions or detect illness. The team from Massachusetts Institute of Technology (MIT) claim this is the first example of a fabric which can record data in a digital rather than in an analogue format, allowing it to be programmed like any other digital device.
Outsourcing Pharma
JUNE 7, 2021
The virtual clinical development firmâs analysis of patient profiles reflects obesity is the most significant indicator for severity in those under 40.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
JUNE 8, 2021
Anyone with a smart device has been feeling the grueling effects of social isolation and screen fatigue since the start of the COVID-19 outbreak. Recently, we have witnessed a flood of new “audio-social apps” and audio features on social media platforms, aiming to finds new ways to connect, curb loneliness and cut excessive screen exposure. What are some of these audio-focused platforms and where can pharma play a role?
Pharma Mirror
JUNE 11, 2021
In the new normal scenario of Healthcare, where the approaches are patient-centric and no longer product-centric, traditional and integrative medicinal practices are rooting to the greater extent so does the ‘Ethno-pharmacy’ At the intersection of social and natural sciences, Ethno-pharmacy is a field that focuses on the traditional medicines (and pharmaceuticals) and the cultural determinants to investigate the possible use/perception of traditional medicines (and also pharmaceutica
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JUNE 9, 2021
“Rarely does the answer come from the boardroom” – what can user experience teach us about building accessible digital health? No one should be left behind as the world embraces digital healthcare say leading user experience voices. The experts discussed the benefits and merits of co-creation during a session on bridging the digital divide, held during the recent Patient Experience Digital Summit.
Outsourcing Pharma
JUNE 7, 2021
The US Food and Drug Administration (FDA) has approved Biogenâs Aduhelm (aducanumab) for the treatment of Alzheimerâs: making it the first new treatment approved for the disease since 2003.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Mirror
JUNE 10, 2021
Completes Acquisition of Keytech Water Management of Canada Minneapolis, MN: Kurita Water Industries (Kurita) (Headquarters, Tokyo, Japan), a leading global provider of water treatment solutions, today announced the completion of its acquisition of Keytech Water Management (“Keytech”) through its North American subsidiaries in a stock purchase deal.
pharmaphorum
JUNE 11, 2021
A digital therapeutic aimed at people with chronic lower back pain based on virtual reality (VR) has shown encouraging results in a clinical trial, helping patients manage the fear of movement that can reduce their activity and impede recovery. The therapy uses a VR headset to guide people with chronic pain through a series of cognitive behavioural therapy (CBT) exercises that are designed to help them overcome the fear of movement – also known as kinesiophobia.
Outsourcing Pharma
JUNE 8, 2021
In partnership with 23andMe, the group has released a wealth of new de-identified data from the largest-ever Parkinsonâs cohort, to aid future research.
Pharma Marketing Network
JUNE 10, 2021
Robin Kamen is an experienced innovator in digital strategy with a deep background in leadership positions for healthcare and consumer products companies. She has worked with many omnichannel brands to use digital marketing technologies to improve B2C and B2B customer engagement funnels and drive sales and retention. She is also skilled in developing the change management often needed to secure buy-in for and to successfully operate digital strategies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Lifewell Rx Pharmacy
JUNE 9, 2021
According to a study published in the National Library of Medicine, medication non-adherence may lead to “worsening condition, increased comorbid diseases, increased health care costs, and death.” To prevent this, patients must work with a pharmacy to store prescriptions correctly. For example, packaging plays a vital role in promoting medication adherence.
pharmaphorum
JUNE 11, 2021
The development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare. However the increased complexity and involvement of different parties, exposes manufacturers to heightened threat levels. Abel Archundia discusses how COVID-19 has highlighted the importance of securing clinical trials against cyber threats.
Outsourcing Pharma
JUNE 7, 2021
The pharmacy company's Wegovy (semaglutide) is the first therapy designated for chronic weight management that the agency has granted approval since 2014.
Pharma Marketing Network
JUNE 9, 2021
Join PMN on July 15th for our premier event on Customer Experience, where we will discuss best practices for moving beyond buzzwords to elevate experience and drive true patient and provider engagement based on empathy and data insights. Hear from leading Experience and Omnichannel experts from Merck, BMS, Novartis, AstraZeneca, UCB, AbbVie, and more on winning strategies to transform data into actionable strategy, elevate CX beyond campaign optimization and activate the “Engagement Matrix” in y
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Mirror
JUNE 6, 2021
Terrassa (Barcelona): Telstar will be exhibiting the latest developments in aseptic technology for pharmaceutical production and integrated turnkey engineering & construction services for process facilities at Achema Pulse 2021. The company will be present at the digital flagship event of the global process industries during the whole of June and will be live during 15-16th June.
pharmaphorum
JUNE 8, 2021
Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. Home to over 60% of the world’s population, Asia Pacific (APAC) is not a region the biopharma industry can afford to ignore. Dr Jay Mei, founder and CEO of Antengene, notes that the region has rich innovation resources but also urgent medical needs, leading to both opportunities and uncertainties for the industry.
Outsourcing Pharma
JUNE 8, 2021
A leader from the manufacturing technology provider talks about how companies can work to streamline oral solid dose manufacturing to remain competitive.
Pharma Marketing Network
JUNE 7, 2021
Tom Croce is vice president for global patient advocacy at bluebird bio, inc., the clinical-stage biotech company that develops gene therapies for severe genetic and rare diseases. He and his team are responsible for identification and integration of patient perspectives across the entire development and commercial continuum, while ensuring meaningful company representation to patient, caregiver and advocate partners around the world.
Pharma Mirror
JUNE 6, 2021
Emergency medical response requires a coordinated effort. It’s a field that burdens people with the task of providing an organized and immediate medical response in an often chaotic and high-pressure environment. To be able to do this in a consistent and timely manner, many emergency medical services (EMS) providers rely on electronic patient care reports (ePCR) solutions. ePCR is critical to the operation of EMS organizations because it allows staff members and response coordinators to stay on
pharmaphorum
JUNE 7, 2021
Novartis’ Kymriah has had the CAR-T therapy market for acute lymphoblastic leukaemia (ALL) to itself so far, but Gilead Sciences’ Kite subsidiary is now looming in the rear view mirror – armed with new data for its already-filed rival Tecartus. Results of the phase 1/2 ZUMA-3 trial of Tecartus (brexucabtagene autoleucel) reported at the ongoing ASCO conference revealed a 71% complete response rate with the CAR-T in heavily pre-treated adult patients with B-cell precursor ALL.
Outsourcing Pharma
JUNE 10, 2021
A leader from the virtual research solutions specialist discusses how a greater pushed toward home-based research can lead to a range of benefits.
Med Ed 101
JUNE 9, 2021
I get quite a few questions about preparing for the BCMTMS exam. I’ve been fortunate to receive feedback from many candidates now regarding our content and how to best tailor our educational approach. I’m happy with the testimonials that we have received that make me believe we provide the best resources on the market that […]. The post Preparing For The BCMTMS Exam in 2021-2022 appeared first on Med Ed 101.
Pharma Mirror
JUNE 5, 2021
Ashfield Engage, part of UDG Healthcare plc, today announced that it has been selected by US-based Pacira BioSciences, Inc. to provide strategic commercialization services for its non-opioid pain management products in select European countries. Pacira has partnered with Ashfield Engage to develop a commercial strategy and deliver outsourced operations in numerous European countries, including the UK, Germany, Sweden, Austria, Netherlands and Finland.
pharmaphorum
JUNE 9, 2021
The unexpected approval and lofty pricing of Biogen’s Alzheimer’s therapy Aduhelm is clearly the biopharma event of the year so far, but what are the broader implications for the industry as a whole? Analysts at RBC Capital Markets say that the decision points to an unprecedented shift in position for the FDA when it comes to regulating drugs for neurological and psychiatric disorders – and while the potential for Aduhelm may still be speculative , other drug developers could see big
Outsourcing Pharma
JUNE 8, 2021
Dutch biotech, Byondis, today announced positive topline results from a Phase 3 study, which it says confirms the safety and efficacy of its antibody drug conjugate (ADC) - SYD985 - as a treatment for patients with pretreated HER2-positive locally advanced or metastatic breast cancer (MBC).
Pharma Times
JUNE 9, 2021
The MHRA has issued an EAMS scientific opinion opening the door to use of cipaglucosidase alfa with miglustat in eligible patients with Pompe disease
Druggist
JUNE 8, 2021
Venlafaxine & weight gain? The focus of this post is to explore evidence be one of the most common side effects of venlafaxine. Additionally, I will talk about other aspects of venlafaxine, including licensed use, and common side effects. What is Venlafaxine? Venlafaxine is an antidepressant drug used to treat major depression, general and social anxiety disorders and panic conditions (BNF, 2021).
pharmaphorum
JUNE 11, 2021
The fallout over the FDA’s decision to approved Biogen’s Alzheimer’s therapy Aduhelm continues to be felt, with a third member of its advisory committee resigning in protest. . The latest to depart the FDA’s Peripheral and Central Nervous System Drugs panel is Aaron Kesselheim of Harvard Medical School, joining fellow committee members Joel Perlmutter and David Knopman who quit earlier this week.
Outsourcing Pharma
JUNE 8, 2021
The US agencyâs latest actions and advice against the virus include information on test recalls, , approval and reauthorization of treatments, and more.
Pharma Times
JUNE 8, 2021
Tecentriq is indicated for adults with metastatic NSCLC if their tumours have PD-L1 expression on at least 50% of tumour cells or 10% of tumour-infiltrating immune cells
pharmaphorum
JUNE 8, 2021
The FDA “has failed in its responsibility to protect patients and families from unproven treatments with known harms” in approving Biogen’s Alzheimer’s disease drug Aduhelm. That was the damning conclusion of the influential Institute for Clinical and Economic Review (ICER) in the US to yesterday’s approval of Aduhelm (aducanumab), the first new treatment for Alzheimer’s since 2003, which it says has “no evidentiary basis.” Biogen meanwhile has bee
pharmaphorum
JUNE 8, 2021
The UK’s decision to set back the start date of a new patient data-sharing scheme by two months has been welcomed by privacy campaigners, who have claimed it was being rushed through without sufficient public scrutiny. The centralised database of medical records from 55 million people was due to come online on 1 July, but the start date has now been pushed back to 1 September, according to Minister for Public Health, Primary Care & Prevention Jo Churchill.
pharmaphorum
JUNE 7, 2021
The ways in which HCPs prefer to engage with pharma has been changing for quite some time, and the digital transformation brought by COVID has dramatically accelerated that. In a recent pharmaphorum webinar, in partnership with Axtria , commercialisation experts from across the industry discussed how the right field force training and execution in combination with the appropriate technology can help to transform this engagement model.
pharmaphorum
JUNE 11, 2021
Sanofi’s hopes of a speedy approval of first-in-class C1s inhibitor sutimlimab in rare disorder cold agglutinin disease (CAD) were dashed by the FDA, but new phase 3 data keep the drugmaker on track for a resubmission before year-end. The results of the 42-subject CADENZA study – reported at the ongoing European Haematology Association (EHA) – showed that sutimlimab was able to reduce the destruction of red blood cells (haemolysis) seen in patients with CAD within one week of starting trea
Expert insights. Personalized for you.
145 
Let's personalize your content